Oppenheimer analyst Suraj Kalia downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Perform.
What 7 Analyst Ratings Have To Say About Keysight Technologies
Keysight Technologies (NYSE:KEYS) has observed the following analyst ratings within the last quarter: